Moderna’s stock fell $60.06 after surging 39% over six sessions, marking its first decline in a week.
Moderna (NASDAQ) shares declined 6.1% to $60.06 in afternoon trading, halting a six-session winning streak. The drop followed a 39% surge over the prior six days, outpacing broader market gains.
The stock had been a standout performer, though the recent rally lacked a clear catalyst. Trading volume remained in line with recent averages, suggesting profit-taking rather than a fundamental shift.
No immediate market reaction to the decline was reported, with broader indices holding steady.